| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AIFM2 | CTRPv2 | pan-cancer | AAC | -0.33 | 4e-20 |
| mRNA | SRXN1 | CTRPv2 | pan-cancer | AAC | -0.27 | 2e-15 |
| mRNA | PGD | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-15 |
| mRNA | RP5-850E9.3 | CTRPv2 | pan-cancer | AAC | -0.27 | 2e-15 |
| mRNA | SLC7A11 | CTRPv2 | pan-cancer | AAC | -0.25 | 4e-14 |
| mRNA | GSR | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-12 |
| mRNA | ME1 | CTRPv2 | pan-cancer | AAC | -0.25 | 1e-12 |
| mRNA | AKR1C1 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-12 |
| mRNA | NQO1 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-12 |
| mRNA | OSGIN1 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-12 |
